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A B S T R A C T
We report a child with myocardial necrosis, dilated cardiomyopathy, and severe mitral valve (MV) regurgitation
following neonatal enteroviral myocarditis. He underwent MV annuloplasty at 18 months and MV replacement at
3 years of age. He remains asymptomatic on medical therapy at 8 years of age. Mitral valve surgery may stabilize the
evolution of dilated cardiomyopathy and delay the ultimate need for heart transplant.
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Introduction
Neonatal enteroviral myocarditis is a devastat-ing disease and often leads to severe cardiac
consequences such as dilated cardiomyopathy
(DCM), which, in turn, is associated with 31%
reported mortality.1 In DCM, functional mitral
regurgitation (MR) develops because of incom-
plete leaflet coaptation secondary to a change in
the mitral valve (MV) apparatus and altered ven-
tricular geometry.2 Mitral regurgitation may cause
further annular dilation, progressive worsening of
MR, and left ventricular (LV) dysfunction. In a
study of 42 children with idiopathic DCM, MR
severity was an independent risk factor for worse
clinical status and death or transplantation.3
Dilated cardiomyopathy is the most common
indication for orthotopic heart transplant (OHT)
in children.4 Although OHT is a definitive treat-
ment, donor availability is limited, recipients
require lifelong antirejection medications, and the
life span of a transplanted heart is limited. There-
fore, nontransplant surgical therapies of end-stage
cardiomyopathy are topics of recent investigations
and may enable OHT to be postponed or avoided,
although experience in children is limited. We
report a case with severe MR associated with
DCM and myocardial necrosis following neonatal
enteroviral myocarditis, in which MV annulo-
plasty and subsequent mitral prosthetic valve
replacement successfully stabilized the evolution
of DCM and has obviated need for OHT thus far.
In addition, we present a review of the literature
on outcomes of surgical approaches for DCM in
children.
Case Report
A 9-day-old, full-term male infant presented with
cardiogenic shock. He was born via normal vaginal
delivery with a birth weight of 3600 g without
significant antenatal or immediate neonatal com-
plications. An echocardiogram at presentation
showed normal intracardiac anatomy, normal
aortic arch, severely dilated LV, and severe LV
dysfunction with severe mitral and tricuspid regur-
gitation. Because of paradoxical ventricular septal
motion, the LV ejection fraction (LVEF) or short-
ening fraction could not be measured accurately.
The estimated right ventricular systolic pressure
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(RVSP) was 56 mm Hg plus right atrial pressure.
The coronary arteries appeared to have a normal
origin. There was a small pericardial effusion.
Troponin I was >50 ng/mL (normal range <2) and
CK-MB was 131 ng/mL (normal range <10).
Rectal and nasopharyngeal viral culture and poly-
merase chain reaction in blood were found to be
positive for enterovirus confirming a diagnosis of
enteroviral myocarditis. The electrocardiogram
(ECG) showed deep and wide Q wave in V6 and
ST elevation in inferior leads and ST depression in
the right precordial leads, suggestive of myocardial
ischemia. The infant was supported hemodynami-
cally by multiple inotropes, and enteroviral infec-
tion was treated with the antienteroviral agent
pleconaril and intravenous immuoglobulin. He
was discharged home 36 days later with improve-
ment of LV function. The LV function (LVEF
44%) was moderately decreased with trivial MR
and akinesia of the LV posterior basilar region.
During follow-up, he was noted to have failed
to thrive, and at 17 months of age, echocardio-
graphy showed severe MR and LV dilation
(LV end-diastolic dimension [LVEDD] 43 mm,
z-score +6.2) and an increase in the estimated
RVSP. LVEF was 48%. Cardiac catheterization
was performed to assess the hemodynamics and
showed a mildly elevated RVSP (36 mm Hg). The
left pulmonary capillary wedge pressure (mean
12 mm Hg) and LVED pressure (11 mm Hg) were
elevated with no evidence of significant MV steno-
sis. The calculated pulmonary vascular resistance
(PVR) was 2.2 indexed Woods units. Coronary
angiography showed no focal stenosis or aneu-
rysm. Mitral valve annuloplasty was performed at
18 months of age as a bridge to OHT. Intraopera-
tive inspection revealed a large, oval-shaped,
bright akinetic area measuring 6 ¥ 4 cm in the
postero-basal wall of the LV. The MV was mor-
phologically normal with a dilated annulus mea-
suring 22 mm in diameter. A horizontal mattress,
pledgetted 4-0 Prolene (Ethicon, Somerville, NJ,
USA) suture was placed from the inferior
commissure along the posterior-inferior portion
of the annulus. The MV annulus diameter was
tightened to 16 mm. Intraoperative transesoph-
ageal echocardiography showed trivial MR
(Figure 1). However, as inotropes were weaned, by
discharge, he developed moderate MR with LVEF
of 50%. He continued to be managed medically
with captopril, digoxin, furosemide, and aspirin.
Mitral regurgitation and LV dysfunction gradu-
ally progressed over the next 1 year. At 32 months
of age, echocardiography showed severe LV dila-
tion (LVEDD 44 mm, z-score 5.1) with severe
MR and LVEF of 50%. Except for failure to
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Figure 1. Intraoperative transesophageal echocardiography (A) before and (B) after mitral valve annuloplasty. Mitral
annulus and mitral regurgitation was significantly reduced.
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thrive, he remained asymptomatic and weighed
11.3 kg (second percentile). At 3 years of age,
cardiac catheterization was performed, and the LV
was found to be moderately dilated with further
elevation of the LVED pressures to 14 mm Hg
and a normal RVSP (32 mm Hg). The PVR was
4.5 indexed Woods units. After extensive discus-
sion, because of worsening of the LVED pressure
and failure to thrive, the decision was made to
perform MV replacement (MVR). The MV was
replaced with a St. Jude 21 mm diameter mechani-
cal prosthesis (St. Jude, Minneapolis, MN, USA).
The postoperative course was uncomplicated.
Postoperatively, he continued to remain free of
respiratory symptoms and experienced an
improvement in body weight on a medical
regimen of coumadin and enalapril.
He did develop a gradual increase in the gradi-
ent across the prosthetic MV without an increase
of the estimated RVSP. At 7 years of age, the
echocardiogram showed that the mean pressure
gradient across the prosthetic MV was signifi-
cantly increased at 15 mm Hg with an estimated
RVSP of 58 mm Hg. Cardiac catheterization dem-
onstrated a severely elevated left atrial (LA) pres-
sure with a mean of 18 mm Hg and a V wave of
30 mm Hg. The A wave of the LA pressure was
similar to the LVED pressure of 15 mm Hg. The
RVSP was 59 mm Hg (two-thirds of systemic).
The PVR was 4.8 indexed Woods units. The pos-
terior leaflet of the prosthetic MV was immobile
on fluoroscopy (Figure 2). He underwent surgical
debridement of the MV. Intraoperatively, signifi-
cant psuedointima, fibrous ingrowth, and throm-
bus were noted around the entire MV annulus.
After debridement, the valve regained normal
function. At the latest follow-up at 8 years of
age, he remains asymptomatic. Echocardiogram
showed normal mobility of both leaflets of the
prosthetic MV. The mean gradient across the MV
was 5 mm Hg. The LV function was moderately
reduced but unchanged with LVEF of 47%. The
estimated RVSP was 37 mm Hg with a LVEDD of
51 mm (z-score +5.2).
Discussion
Mitral valve regurgitation is frequently associated
with DCM and is reported to be associated with
worsening of DCM and to be an independent risk
factor for need for OHT.3 An intervention to
decrease MR leads to improvement in LV volume
and decreased LA volume overload and may
prevent LV remodeling. Therefore, early repair of
the MV has been tried in adults to obviate or delay
the need for OHT. There is limited experience
with early MV repair in children with DCM. In
our case, first MV annuloplasty and subsequent
MVR has averted the need for OHT until 8 years
of age.
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Figure 2. Cardiac catheterization at 7 years old, prior to surgical debridement of mitral prosthetic valve. (A) RAO 30°. Using
the transseptal approach, the Berman angio catheter was advanced into the left atrium. Angiography in the left atrium
showed dilated left atrium and left ventricle with prosthetic mitral valve. (B) Fluoroscopy of prosthetic mitral valve (21 mm
diameter St. Jude) showed that posterior leaflet was immobile.
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Nontransplant surgical therapies of end-stage
cardiomyopathy are rapidly evolving and include
MVR, MV repair, and partial left ventriculectomy
(PLV). We performed a literature review of non-
transplant surgeries for DCM in children.2,5–17 A
total of 33 children in the literature underwent
MVR, MV repair, and/or PLV at a median age of
26 months (range 3 days–10.9 years) and a median
weight of 7 kg (range 3.3–12 kg) (Table 1). Sixteen
children underwent MV repair, seven underwent
PLV and MV repair, five underwent PLV, and five
underwent MVR. Among those, two children
had previous MV repair before MV repair, one
had previous MV repair before MVR, and two had
PLV before MVR. The follow-up duration of the
reported cases is generally short. During the
median follow-up of 7 months (range 1 week–17
years), the mortality rate was 15% at a median
duration of 47 days (20 days–2 months) from the
surgery. Eleven (33%) children underwent OHT
at a median duration of 7 months (range 1 month–
2.3 years) from the surgical intervention. The
nontransplant surgical approaches acted as a
bridge to OHT in these cases with fair efficacy
(51% survival without OHT). The severity of
heart failure varies among patients with MR and
DCM. Although successful MV surgery has been
reported as an urgent rescue in patients with
uncompensated heart failure, early postoperative
mortality cannot be ignored. In the review of
literature, most patients required presurgical
intravenous inotropes but electively underwent
nontransplant surgeries prior to the stage of
uncompensated heart failure necessitating
mechanical ventilator support. In contrast, two
patients were on mechanical ventilation prior to
the surgery: one patient was treated with extracor-
poreal membrane oxygenation and died 47 days
after surgery, while the other patient was on high
dose inotropes and mechanical ventilator under-
went successful MV repair and subsequent OHT.14
For critically ill patients, ventricular assist device
and/or extracorporeal cardiopulmonary mem-
brane oxygenation may be safer choices of therapy
as bridge to transplant. Nontransplant surgeries
may have a role as urgent rescue and to wean
inotropes and ventilation.
Mitral valve replacement is an alternative sur-
gical option when MV repair is not possible for
MV diseases.18 However, MVR is challenging in
young children because of the limited availability
of adequate-sized prosthesis, the need for antico-
agulation, and the poor long-term outcome.18 In
the multiinstitutional study of 139 children aged
<5 years undergoing MVR, the 10-year survival
was 74% with a 5-year freedom from reoperation
of 81%.19 The risk of second MVR was highest in
children who were <2 years old and received a
prosthesis <20 mm at the initial MVR.20 The
reasons for a secondary MVR were prosthetic
valve stenosis 83%, thrombosis 14%, and
endocarditis 3%.20 In our patient, MVR was per-
formed using a 21 mm prosthetic valve at 3 years
of age after a failed MV repair. Mitral valve
replacement was selected at the second operation
instead of repeated MV repair, because MVR was
deemed to have a secure surgical outcome.
Whereas, MV repair had a likelihood of failure
again because of papillary muscle dysfunction.
The prosthetic valve was rescued by surgical
debridement of fibrous tissue and thrombus, when
prosthetic valve dysfunction occurred 4 years after
insertion.
Neonatal enteroviral myocarditis is a devastat-
ing disease, which often leads to chronic heart
failure, aneurysm formation within the LV, and
MR.1 In a review of 35 cases of neonatal enterovi-
ral myocarditis, the mortality was 31% and 66%
of survivors developed severe cardiac sequelae.1
Myocardial infarction has been reported in cases
of neonatal enteroviral myocarditis.21 It is unclear
whether enterovirus-induced myocardial necrosis
mimics myocardial infarction. The difficulties in
differentiating between neonatal myocardial inf-
arction and myocarditis were discussed by de
Vetten et al.22 Clinical presentation and diagnostic
findings such as ECG changes and regional wall
motion abnormalities are similar in both entities.
Freund et al. advocated that the absence of the
R wave and the presence of a new Q wave in I, II,
and left precordial leads on ECG may be useful
to diagnose neonatal myocarditis.1 In our case,
myocardial infarction was suspected because of a
Q wave on ECG and because of akinesia of the
LV posterior basilar region on echocardiography.
However, subsequent coronary angiography
showed no discrete stenosis. Although the possi-
bility of spontaneous recanalization of the coro-
nary artery cannot be excluded, our case was likely
to have an enterovirus-induced myocardial necro-
sis. In enterovirus-induced myocarditis in neo-
nates, myocardial damage occurs by direct
myocyte lysis and apoptotic damage to the
infected myocytes.1 This myocyte necrosis may
mimic a myocardial infarction in the absence of
any localized ischemia.1 Subsequently necrosis is
repaired by scar formation and aneurysm forma-
tion. Although the effect of enterovirus on the
Kobayashi et al.E62
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endothelium of the coronary vasculature is not
well described, a microvascular coronary arteritis
is a putative mechanism of entroviral myocarditis-
induced infarction.21 Other postulated mecha-
nisms included coronary thrombosis, coronary
artery spasm, coronary embolism, and large vessel
coronary arteritis.21This could be a possible expla-
nation for posterobasal aneursym formation in our
case.
Conclusion
We report a challenging pediatric case with DCM
and severe MR following neonatal enteroviral
myocarditis in which MV surgery such as annulo-
plasty and prosthetic valve replacement success-
fully stabilized the evolution of DCM and has
obviated the need for OHT thus far. In our review
of the literature, we found a 51% rate of survival
without OHT among 33 cases in which surgical
interventions were performed. Mitral valve
surgery may be considered as a therapeutic option
in children with severe MR and DCM to obviate
need for OHT.
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